Alpha RegistryClaim a profile
Published mark

Lineage Cell Therapeutics, Inc.

NYSE: LCTX. Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, developing cell replacement therapies to treat serious medical conditions in the United States and internationally.

US

Record source reportedRecord not claimedNo Eval published
Follow companySave PDF
Alpha ID
alpha:company:564c5cf5-a5fb-49a6-bdce-0982655c7ab6
SEC CIK
0000876343
Record version
vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce, published Oct 22, 2026
Newest evidence
Apr 29, 2026
Monitoring
Not yet monitored Details
Integrity
Not yet signed Methodology
CEO
Brian M. CulleyChief Executive Officer
Chair
Michael H. Mulroy
Independent
Not published7 directors published
Published claims
282 distinct sources
Evidence records
40 pinned
Source conflicts
0None open

Built from 2 distinct sources and 4 evidence records. Every Claim links to where it appears. Where nothing was published, the record states the coverage gap.

CorroboratedSource reportedAlpha inferenceNot disclosed

Public record. Alpha publishes governance facts about this organization from regulatory filings and company statements. Private enterprise overlay data is never projected here. The company can claim the record, correct, or dispute any Claim. How this works

DIRECTOR APPOINTED

Anula Jayasuriya seat on Lineage Cell Therapeutics, Inc., effective 2021-01-01.

EffectiveEffective Jan 1, 2021E3

Monitoring

Continuous

What the published record states about identity, evidence, evaluation, monitoring, authority, and freshness. Watched-source schedules are not published for this record.

  • Identityunclaimed
    Published
  • Evidencesource_reported
    Published
  • Evaluationnot_evaluated
    Published
  • MonitoringNot yet published for this record.
    Not published
  • AuthorityNot yet published for this record.
    Not published
  • Freshnesscurrent
    Published

Leadership

Evidence
RolePersonSinceStatusClaim
Chief Executive OfficerBrian M. CulleyNot capturedunknownSource reportedE2
General Counsel and Corporate SecretaryGeorge A. Samuel IIINot capturedunknownSource reportedE2
Chief Financial OfficerJill A. HoweNot capturedunknownSource reportedE2

Board of directors

Evidence

7 directors published. Independence determinations are not published for every director.

DirectorStatusSinceCommitteesClaim
Angus C. RussellIndependence not published2014Audit CommitteeCompensation Committee, chairSource reportedE3
Anula JayasuriyaIndependence not published2021Nominating & Corporate Governance CommitteeSource reportedE3
Brian M. CulleyIndependence not published2018None publishedSource reportedE3
Deborah AndrewsIndependence not published2014Audit Committee, chairCompensation CommitteeSource reportedE3
Dipti AminIndependence not published2021Compensation CommitteeSource reportedE3
George A. Samuel IIIIndependence not published2021None publishedSource reportedE3
Neal C. BradsherIndependence not published2009Nominating & Corporate Governance Committee, chairSource reportedE3
Michael H. MulroyIndependentChairNot publishedNone publishedSource reportedE2

Committees and risk ownership

Evidence
CommitteeChairMembersRisks assigned
Audit CommitteeDeborah AndrewsDeborah Andrews, Angus C. RussellNot described in the published record
Compensation CommitteeAngus C. RussellAngus C. Russell, Deborah Andrews, Dipti AminNot described in the published record
Nominating & Corporate Governance CommitteeNeal C. BradsherNeal C. Bradsher, Anula JayasuriyaNot described in the published record
Committee RecordAudit Committee: Chair Deborah Andrews; Members Deborah Andrews (Chair); Angus C. Russell
Source reportedE4
company:564c5cf5-a5fb-49a6-bdce-0982655c7ab6:committee_record:18
Committee AppointmentDeborah Andrews: chair, Audit Committee
Source reportedE4
company:564c5cf5-a5fb-49a6-bdce-0982655c7ab6:committee_appointment:19
Committee AppointmentAngus C. Russell: member, Audit Committee
Source reportedE4
company:564c5cf5-a5fb-49a6-bdce-0982655c7ab6:committee_appointment:20
Committee RecordCompensation Committee: Chair Angus C. Russell; Members Angus C. Russell (Chair); Deborah Andrews; Dipti Amin
Source reportedE4
company:564c5cf5-a5fb-49a6-bdce-0982655c7ab6:committee_record:21
Committee AppointmentAngus C. Russell: chair, Compensation Committee
Source reportedE4
company:564c5cf5-a5fb-49a6-bdce-0982655c7ab6:committee_appointment:22
Committee AppointmentDeborah Andrews: member, Compensation Committee
Source reportedE4
company:564c5cf5-a5fb-49a6-bdce-0982655c7ab6:committee_appointment:23
Committee AppointmentDipti Amin: member, Compensation Committee
Source reportedE4
company:564c5cf5-a5fb-49a6-bdce-0982655c7ab6:committee_appointment:24
Committee RecordNominating & Corporate Governance Committee: Chair Neal C. Bradsher; Members Neal C. Bradsher (Chair); Anula Jayasuriya
Source reportedE4
company:564c5cf5-a5fb-49a6-bdce-0982655c7ab6:committee_record:25
Committee AppointmentNeal C. Bradsher: chair, Nominating & Corporate Governance Committee
Source reportedE4
company:564c5cf5-a5fb-49a6-bdce-0982655c7ab6:committee_appointment:26
Committee AppointmentAnula Jayasuriya: member, Nominating & Corporate Governance Committee
Source reportedE4
company:564c5cf5-a5fb-49a6-bdce-0982655c7ab6:committee_appointment:27

Control and voting power

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Authority to act

Evidence and agent registry

Who can act for the company, and on whose authority. This is what a counterparty's agent checks before it accepts an order, signs, or pays.

Principal executive officerBrian M. Culley, Chief Executive Officer
Source reportedE2
company:564c5cf5-a5fb-49a6-bdce-0982655c7ab6:leadership_role:15
Who can authorize an agentNot assessedNo Alpha inference about signing authority or board-reserved matters is published for this record.
Not assessed
bind
AI agents registered by the companyNot registered in the public RegistryAgent Deployments, Agent Use Cases, Authority Grants, TrustChecks, Action Ledger entries and Governance Receipts live in the private enterprise overlay. They are never projected into the public Registry without explicit cross-plane authorization. Absence here is a plane boundary, not evidence that the enterprise operates no agents.
Agent registry
agents
Delegations publishedNot disclosedBoard and officer delegation resolutions are not public filings and are not published in this record.
Search scope
delegations

Financials and market context

Evidence
Security ListingLCTX (NYSE)
Source reportedE1
company:564c5cf5-a5fb-49a6-bdce-0982655c7ab6:security_listing:28
Security ListingLCTX (NYSE AMERICAN)
Source reportedE1
company:564c5cf5-a5fb-49a6-bdce-0982655c7ab6:security_listing:29
Index membershipsNo current membership is published in Alpha's tracked index universe.This is not evidence that the company is absent from every market index.
None publishedAs of Oct 22, 2026. Rights-filtered public evidence only; no redistribution or model training is granted. Only source-backed memberships with an explicit public redistribution basis are returned.

Governance and policies

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Risk, audit, and cyber

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

AI oversight and accountability

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Compensation

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Other published claims

Evidence

Published Claims that belong to no section above. Each keeps its permalink, evidence, and assertion state.

Legal NameLineage Cell Therapeutics, Inc.
Source reportedE1
company:564c5cf5-a5fb-49a6-bdce-0982655c7ab6:legal_name:1
Entity StatusPublic listing published
Source reportedE1
company:564c5cf5-a5fb-49a6-bdce-0982655c7ab6:entity_status:3
Published FactHealthcare
Source reportedE1
company:564c5cf5-a5fb-49a6-bdce-0982655c7ab6:published_fact:5
Published FactBiotechnology
Source reportedE1
company:564c5cf5-a5fb-49a6-bdce-0982655c7ab6:published_fact:6

Not yet in this record

Coverage

A gap is a coverage state, not a negative finding. These sections are expected for this entity class and are not yet published.

  • Corporate structureNot reviewed. Parent, subsidiary and predecessor structure explains who is governed.
  • OwnershipNot reviewed. Ownership and voting power determine who can influence the board.
  • FinancialsNot reviewed. Governance-relevant financial context frames capital and audit decisions.
  • CompensationNot reviewed. Pay design shows how incentives are governed.
  • GovernanceNot reviewed. Governing documents and provisions set the rules of the enterprise.
  • Shareholder governanceNot reviewed. Meeting and vote records show shareholder dissent and support.
  • AuditNot reviewed. Auditor, controls and restatements show assurance over reporting.
  • LegalNot reviewed. Material legal and regulatory matters show enforcement exposure.
  • RiskNot reviewed. Risk ownership links the board, committees, executives and controls.
  • CyberNot reviewed. Cyber and data governance is a disclosed oversight domain.
  • AI governanceNot reviewed. AI oversight is a differentiated Alpha governance domain.
  • Markets externalNot reviewed. Auditors, advisors, investors and regulators form the external ecosystem.
  • Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
  • Only explicitly published canonical company identity and current confirmed public roles are included.Only explicitly published canonical company identity and current confirmed public roles are included.
  • Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
  • Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
  • This Company Profile is an identity and evidence record, not an Alpha rating.This Company Profile is an identity and evidence record, not an Alpha rating.

Subject and corrections

Public-role doctrine

This record exists because the company is in the published Registry. The company can claim the record, correct, or dispute any Claim. Corrections are versioned and the original stays in history.

Basis
Published company record built from public sources
Sources
4 evidence records cited. 0 with redistribution rights.
Never published
Private enterprise overlay data: deployments, authority grants, TrustChecks, receipts, telemetry
Record claimed
No
Open disputes
0
Identity ownership
unclaimed
Claiming not yet available

If the company claims the record, its statements appear as their own assertion state and never overwrite the cited evidence.

Evidence

Authority and rights
  1. E1
    Alpha canonical company public projection
    Alpha canonical company public projection. canonical identity. Retrieved Oct 22, 2026. Cited by 7 Claims.
    Open web
    Rights not recorded, link only
    Evidence not pinned
  2. E2
    SEC DEF 14A 0001193125-26-191556
    sec def 14a. Published Apr 29, 2026. Retrieved Sep 6, 2026. Cited by 4 Claims.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  3. E3
    DEF 14A lctx-20260429.htm
    sec proxy. Published Apr 29, 2026. Retrieved Sep 2, 2026. Cited by 7 Claims.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  4. E4
    Audit Committee
    governance_people_committees. sec proxy. Cited by 10 Claims.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned

What changed in version public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce

vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce published Oct 22, 2026
  • Anula Jayasuriya seat on Lineage Cell Therapeutics, Inc., effective 2021-01-01.
  • Dipti Amin seat on Lineage Cell Therapeutics, Inc., effective 2021-01-01.
  • George A. Samuel III seat on Lineage Cell Therapeutics, Inc., effective 2021-01-01.
  • Brian M. Culley seat on Lineage Cell Therapeutics, Inc., effective 2018-01-01.
  • Angus C. Russell seat on Lineage Cell Therapeutics, Inc., effective 2014-01-01.
  • Deborah Andrews seat on Lineage Cell Therapeutics, Inc., effective 2014-01-01.
  • Neal C. Bradsher seat on Lineage Cell Therapeutics, Inc., effective 2009-01-01.
Appearance

Alpha Governance PBC. The Registry records reported facts and Alpha's assessments separately. A missing fact is not evidence that it is false.

Record alpha:company:564c5cf5-a5fb-49a6-bdce-0982655c7ab6, version public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce. https://registry.alpha.ac/companies/lineage-cell-therapeutics-inc

Navigate

On this record

  1. Overview
  2. Monitoring4
  3. Leadership3
  4. Board8
  5. Committees3
  6. Control and voting0
  7. Authority to act4
  8. Financials2
  9. Governance0
  10. Risk0
  11. AI oversight0
  12. Legal0
  13. Compensation0
  14. Other published claims5
  15. Coverage gaps17
  16. Linked people9
  17. Subject and corrections6
  18. Evidence4
  19. Version historyvpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce

Linked records

Registry

Appearance

esc
  • Actions
    Switch to agent viewJSON, Markdown, MCP
  • Copy Alpha IDalpha:company:564c5cf5-a5fb-49a6-bdce-0982655c7ab6
  • Cite this recordLineage Cell Therapeutics, Inc.
  • Copy canonical URLregistry.alpha.ac/companies/lineage-cell-therapeutics-inc
  • Copy as MarkdownWith assertion states
  • Report an error
  • Theme: System
  • Theme: Light
  • Theme: Dark
  • Records
    Lineage Cell Therapeutics, Inc.Company
  • Brian M. CulleyPerson
  • George A. Samuel IIIPerson
  • Jill A. HowePerson
  • Angus C. RussellPerson
  • Anula JayasuriyaPerson
  • Deborah AndrewsPerson
  • Dipti AminPerson
  • Neal C. BradsherPerson
  • Michael H. MulroyPerson
  • Sections
    OverviewLineage Cell Therapeutics, Inc.
  • MonitoringLineage Cell Therapeutics, Inc.
  • LeadershipLineage Cell Therapeutics, Inc.
  • BoardLineage Cell Therapeutics, Inc.
  • CommitteesLineage Cell Therapeutics, Inc.
  • Control and votingLineage Cell Therapeutics, Inc.
  • Authority to actLineage Cell Therapeutics, Inc.
  • FinancialsLineage Cell Therapeutics, Inc.
  • GovernanceLineage Cell Therapeutics, Inc.
  • RiskLineage Cell Therapeutics, Inc.
  • AI oversightLineage Cell Therapeutics, Inc.
  • LegalLineage Cell Therapeutics, Inc.
  • CompensationLineage Cell Therapeutics, Inc.
  • Other published claimsLineage Cell Therapeutics, Inc.
  • Coverage gapsLineage Cell Therapeutics, Inc.
  • Linked peopleLineage Cell Therapeutics, Inc.
  • Subject and correctionsLineage Cell Therapeutics, Inc.
  • EvidenceLineage Cell Therapeutics, Inc.
  • Version historyLineage Cell Therapeutics, Inc.
↑ ↓ move↵ openThis record only

Report an error

Reports attach to the Claim and go to an Alpha analyst through the correction form. Corrections are versioned, and the original stays in history.